A programme funded by the Bill & Melinda Gates Foundation may have saved around 600,000 people in India from becoming infected with HIV over the course of a decade, according to a new report.
Avahan, the India AIDS Initiative, which was launched in 2003, aimed to prevent HIV transmission in the general population through a comprehensive HIV prevention programme including the promotion of condoms among the people at most risk – female sex workers, high risk men who have sex with men and intravenous drug users – in the six Indian states with the highest HIV rates.
In an evaluation of the project published in Lancet Global Health, researchers estimate that it prevented more than half of the infections that would have occurred without the Avahan intervention.
Avahan, an investment of over $250 million for the Foundation, involved outreach and risk reduction education programmes, condom distribution and social marketing as well as measures aiming to build community resilience and reduce the stigma attached to HIV. Funding and management of the programme is transitioning to the Indian government.
The main part of the evaluation was based on data from 24 districts in south India where Avahan operated, covering the period from 2004 to 2008. The authors used mathematical models to compare the observed trends in HIV infection, estimated through detailed epidemiological studies, with those that would have occurred in the absence of the increase in condom use following the initiative.
They found that in these 24 districts, 62,800 infections were prevented in the first four years of the programme. By extrapolating the results to all 69 districts in south India where Avahan operated, they estimate that 202,000 infections were prevented in those four years, increasing to 606,000 over 10 years.
Dr Marie-Claude Boily, from the School of Public Health at Imperial College London, said: "These findings suggest that the approach used by Avahan, of targeting high risk groups with behavioural interventions, adequate provision of prevention commodities and support for programmes to build community resilience, can be effective at controlling HIV in the population at large. Expanding the coverage of similar programmes could have a considerable impact on HIV epidemics in many parts of the world."
Dr Peter Vickerman, from the London School of Hygiene & Tropical Medicine added: "If replicated, it is possible that the large scale expansion of this intervention to other settings in Asia and Africa could have a demonstrable impact on the worldwide HIV epidemic over the next decade."
Dr Michael Pickles, also from the School of Public Health at Imperial, said: "The design of the evaluation itself, which was planned as an integral part of the programme, was innovative as it combined mathematical modelling with detailed data collection, which enabled us to conduct a rigorous analysis in a situation where it was not possible to conduct community-based randomised trials. Evaluating the impact of prevention programmes is crucial for determining which interventions should be prioritised."
This multidisciplinary study, which was an international collaboration between different institutions, had numerous other components and was carried out through a grant from the Bill & Melinda Gates Foundation to the CHU de Québec for Dr Michel Alary research project. Drs Marie-Claude Boily and Michael Pickles from Imperial College London, UK and Peter Vickerman from the London School of Hygiene and Tropical Medicine were the lead mathematical modellers on this project. The other collaborators of this study were Dr. Anna Vassall from London School of Hygiene & Tropical Medicine, Drs. Stephen Moses and James Blanchard from the University of Manitoba (Winnipeg,Canada), Dr Lalit Dandona from the Public Health Foundation of India (New Delhi, India), Drs. Reynold Washington and B.M. Ramesh from the Karnataka Health Promotion Trust (Bangalore, India) and Dr Tinku Sarah from St-John's Research Institute (Bangalore, India).
For more information please contact:
Research Media Officer
Imperial College London
Tel: +44(0)20 7594 2198
Out of hours duty press officer: +44(0)7803 886 248
Notes to editors
1. M. Pickles et al. 'HIV prevention at scale: has it worked? Evaluation of the impact of the Avahan programme in South India' Lancet Global Health, 2013.
After the embargo the paper can be accessed at http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(13)70083-4/fulltext
2. About Imperial College London
Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.
Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges.
In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible.
3. About the London School of Hygiene & Tropical Medicine
The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with 3,500 students and more than 1,000 staff working in over 100 countries. The School is one of the highest-rated research institutions in the UK, and was recently cited as one of the world's top universities for collaborative research. The School's mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. http://www.lshtm.ac.uk
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.